Abbreviated Company Accounts - CDH BLOODSTOCK LIMITED

CDH BLOODSTOCK LIMITED - Company Information

08330555 CDH BLOODSTOCK LIMITED 2015-12-31 false 2015-01-01 2015-12-31 true 08330555 2015-01-01 2015-12-31 08330555 2015-12-31 08330555 2014-12-31 08330555 uk-gaap-cd-bus:Director1 2015-01-01 2015-12-31 08330555 uk-gaap-cd-bus:Director2 2015-01-01 2015-12-31 uk-gaap-cd-bus:OrdinaryShareClass1 2015-01-01 2015-12-31 uk-gaap-cd-bus:OrdinaryShareClass1 2015-12-31 uk-gaap-cd-bus:OrdinaryShareClass1 2014-12-31 iso4217:GBP shares

Registered Number 08330555

CDH BLOODSTOCK LIMITED

Abbreviated Accounts

31 December 2015

CDH BLOODSTOCK LIMITED Registered Number 08330555

Abbreviated Balance Sheet as at 31 December 2015

	Notes	2015	2014
		£	£
Current assets
Stocks		94,500	-
Debtors		14,535	106,121
Cash at bank and in hand		22,854	42,067
		131,889	148,188
Creditors: amounts falling due within one year		(4,904)	(16,625)
Net current assets (liabilities)		126,985	131,563
Total assets less current liabilities		126,985	131,563
Total net assets (liabilities)		126,985	131,563
Capital and reserves
Called up share capital	2	149,000	149,000
Profit and loss account		(22,015)	(17,437)
Shareholders' funds		126,985	131,563

For the year ending 31 December 2015 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 28 April 2016

And signed on their behalf by:
T F Harris, Director

CDH BLOODSTOCK LIMITED Registered Number 08330555

Notes to the Abbreviated Accounts for the period ended 31 December 2015

1Accounting Policies

Basis of measurement and preparation of accounts
The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).

Turnover policy
Turnover comprises revenue recognised by the company in respect of the sale of bloodstock during the period, exclusive of Value Added Tax.

Valuation information and policy
Bloodstock is valued at the lower of cost and net realisable value

Other accounting policies
Deferred taxation

Full provision is made for deferred tax assets and liabilities arising from all timing differences between the recognition of gains and losses in the financial statements and recognition in the tax computation.

A net deferred tax asset is recognised only if it can be regarded as more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.

Deferred tax assets and liabilities are calculated at the tax rates expected to be effective at the time the timing differences are expected to reverse.

Deferred tax assets and liabilities are not discounted.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the balance sheet date.

Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction.

Exchange gains and losses are recognised in the Profit and loss account.

2Called Up Share Capital
Allotted, called up and fully paid:

	2015 £	2014 £
149,000 Ordinary shares of £1 each	149,000	149,000